Abattis Bioceuticals Corp ATTBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $477.80
- Volume/Avg
- 2,033 / 15,531
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1
- Website
- http://www.abattis.com
Valuation
|
Metric
|
ATTBF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ATTBF
|
|---|---|
Quick Ratio | 0.52 |
Current Ratio | 0.73 |
Interest Coverage | −61.01 |
Quick Ratio
ATTBF
Profitability
|
Metric
|
ATTBF
|
|---|---|
Return on Assets (Normalized) | −30.21% |
Return on Equity (Normalized) | −44.55% |
Return on Invested Capital (Normalized) | −37.30% |
Return on Assets
ATTBF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pmjzvdbq | Lrth | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Wzlxzprbhz | Yzhqgw | $70.9 Bil | |
HLN
| Haleon PLC ADR | Glqbqccj | Yyhc | $37.8 Bil | |
VTRS
| Viatris Inc | Yqmcftgs | Pygf | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zlkvffb | Kjh | $12.7 Bil | |
CTLT
| Catalent Inc | Bvthhnb | Fzkfzd | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Ygmxttgw | Tql | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Yjsxgblf | Wyzvw | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lcnhfbqc | Wsvqmy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Nbqxgpwk | Djr | $3.1 Bil |